Atrinositol

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameAtrinositol
Drug Alias NamePP-56
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNeuropeptide Y receptors antagonistsNeuropeptides inhibitors
TargetsNeuropeptide Y receptorsNeuropeptides
Therapy Area/IndicationsPainDiabetes ComplicationsHypertension +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPerstorp Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPerstorp Group
Active IndicationsN/A
Inactive IndicationsPainDiabetes ComplicationsHypertension +[6] 

Other Information

ATC CodeN/A
Related LinksN/A